UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...

Deutsche Bank (ETR:DBKGn) initiated coverage of Sarepta Therapeutics (NASDAQ:SRPT), assigning a Hold rating to the ...

Deutsche Bank (ETR:DBKGn) initiated coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy rating and a price target of ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of ...

Deutsche Bank Aktiengesellschaft's Q4 results showed an 8.6% revenue increase but a 17% drop in pre-tax profit. Click here to ...

After reaching record highs last year, shares of Monolithic Power Systems have slumped more than 30% since the firm's last earnings report at the end of October, but analysts remain bullish on the ...

Deutsche Bank, one of Europe's biggest lenders, is getting pounded Friday as traders price-in major risks from an expanding U.S. banking crisis. Stock futures slump as bank crisis spreads into ...

Deutsche Bank reported fourth-quarter operating profits of EUR 583 million, missing consensus estimates collected by the bank itself by 38%. Higher operating expenses of EUR 5.276 billion on an ...

Deutsche Bank Aktiengesellschaft upgraded shares of Aptiv (NYSE:APTV – Free Report) from a hold rating to a buy rating in a research report released on Friday morning, Marketbeat reports. The firm ...

HSBC's stock price has dropped more than two per cent this morning after being downgraded by Deutsche Bank analysts from a ...